Last reviewed · How we verify

NCT03597126: R-ISR

Short Term Outcomes of Robotic-assisted Intersphincteric Resection for Low Rectal Cancer

Status unknown NA Last updated 9 December 2021
What this trial tests

NA trial testing Robot-assisted surgery in Rectal Cancer in 100 participants. Status unknown.

Timeline
1 December 2018
Primary endpoint
1 June 2022
1 December 2022

Quick facts

Lead sponsorSouthwest Hospital, China
PhaseNA
StatusStatus unknown
Study typeINTERVENTIONAL
Allocationrandomized
Designparallel
Maskingsingle
Primary purposetreatment
Enrollment100
Start date1 December 2018
Primary completion1 June 2022
Estimated completion1 December 2022
Sites1 location across China

Drugs / interventions tested

Conditions studied

Sponsor

Southwest Hospital, China

Who can join

Adults 18 to 70, any sex, with Rectal Cancer. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

This study compared robot-assisted total mesorectal excision to treat very low rectal cancer within 2 cm from the dentate line to avoid permanent colostomy. improves the quality of life with better defecation function, urinary function and sexual function.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of Robot-assisted surgery

Trials testing the same drug.

Other recruiting trials for Rectal Cancer

Currently open trials in the same condition.

Other Southwest Hospital, China trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03597126.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing